THC Therapeutics, Inc. – OTC:THCT

Founder-led company

THC Therapeutics stock price today

$0.001
+0.00
+11.11%
Financial Health
0
1
2
3
4
5
6
7
8
9

THC Therapeutics stock price monthly change

-69.70%
month

THC Therapeutics stock price quarterly change

-69.70%
quarter

THC Therapeutics stock price yearly change

+900.00%
year

THC Therapeutics key metrics

Market Cap
1.08M
Enterprise value
813.67K
P/E
-0.03
EV/Sales
N/A
EV/EBITDA
-0.26
Price/Sales
N/A
Price/Book
-0.01
PEG ratio
N/A
EPS
0.09
Revenue
N/A
EBITDA
-917.29K
Income
2.98M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

THC Therapeutics stock price history

THC Therapeutics stock forecast

THC Therapeutics financial statements

THC Therapeutics, Inc. (OTC:THCT): Profit margin
Jul 2022 0 1.23M
Jan 2023 0 1.68M
Apr 2023 0 94.35K
Jul 2023 0 -32.94K
THC Therapeutics, Inc. (OTC:THCT): Debt to assets
Oct 2022 56613 5.27M 9325.78%
Jan 2023 23030 3.39M 14738.5%
Apr 2023 13346 3.29M 24653.36%
Jul 2023 12990 3.22M 24810.03%
THC Therapeutics, Inc. (OTC:THCT): Cash Flow
Jul 2022 -23.55K 0 19.76K
Jan 2023 -61.72K 0 66.99K
Apr 2023 -2.17K 0 -6.64K
Jul 2023 -47 0 42

THC Therapeutics alternative data

THC Therapeutics, Inc. (OTC:THCT): Employee count
Aug 2023 1
Sep 2023 1
Oct 2023 1
Nov 2023 1
Dec 2023 1
Jan 2024 1
Feb 2024 1
Mar 2024 1
Apr 2024 1
May 2024 1
Jun 2024 1
Jul 2024 1

THC Therapeutics other data

THC Therapeutics, Inc. (OTC:THCT): Insider trades (number of shares)
Period Buy Sel
May 2010 19001 0
Jun 2010 5000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HO EDEN director, officer: CEO
Common Stock 5,000 N/A N/A
Purchase
HO EDEN director, officer: CEO
Common Stock 19,001 N/A N/A
Insider Compensation
Mr. Brandon Romanek (1975) Chief Executive Officer, Founder, Pres, Sec. & Chairman
$220,000
  • What's the price of THC Therapeutics stock today?

    One share of THC Therapeutics stock can currently be purchased for approximately $0.

  • When is THC Therapeutics's next earnings date?

    THC Therapeutics, Inc. is estimated to report earnings on Tuesday, 2 Sep 2025.

  • Does THC Therapeutics pay dividends?

    No, THC Therapeutics does not pay dividends.

  • How much money does THC Therapeutics make?

    THC Therapeutics has a market capitalization of 1.08M.

  • What is THC Therapeutics's stock symbol?

    THC Therapeutics, Inc. is traded on the OTC under the ticker symbol "THCT".

  • What is THC Therapeutics's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of THC Therapeutics?

    Shares of THC Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are THC Therapeutics's key executives?

    THC Therapeutics's management team includes the following people:

    • Mr. Brandon Romanek Chief Executive Officer, Founder, Pres, Sec. & Chairman(age: 50, pay: $220,000)
  • Is THC Therapeutics founder-led company?

    Yes, THC Therapeutics is a company led by its founder Mr. Brandon Romanek.

  • How many employees does THC Therapeutics have?

    As Jul 2024, THC Therapeutics employs 1 workers.

  • When THC Therapeutics went public?

    THC Therapeutics, Inc. is publicly traded company for more then 8 years since IPO on 23 Jan 2017.

  • What is THC Therapeutics's official website?

    The official website for THC Therapeutics is thct.io.

  • Where are THC Therapeutics's headquarters?

    THC Therapeutics is headquartered at 11700 W Charleston Boulevard, Las Vegas, NV.

  • How can i contact THC Therapeutics?

    THC Therapeutics's mailing address is 11700 W Charleston Boulevard, Las Vegas, NV and company can be reached via phone at 833-420-8428.

THC Therapeutics company profile:

THC Therapeutics, Inc.

thct.io
Exchange:

OTC

Full time employees:

1

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

THC Therapeutics, Inc. operates in the wellness industry. It engages in the developing of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada.

11700 W Charleston Boulevard
Las Vegas, NV 89135

CIK: 0001404935
ISIN: US87248Q1013
CUSIP: 87248Q101